ARTICLE | Distillery Therapeutics
Cancer
December 20, 2016 7:41 PM UTC
Cell culture and mouse studies suggest a GAS6-binding AXL decoy could help treat AML and metastatic breast and ovarian cancers. The AXL decoy, Aravive-S6, consisted of a mutated AXL extracellular doma...